Sulfonylurea treatment in young children with neonatal diabetes: dealing with hyperglycemia, hypoglycemia, and sick days.
Codner
Ethel
E
Flanagan
Sarah E
SE
Ugarte
Francisca
F
García
Hernán
H
Vidal
Teresa
T
Ellard
Sian
S
Hattersley
Andrew T
AT
D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005905:Glyburide / Q000627:therapeutic use; D006304:Health Status; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D007003:Hypoglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D000099161:Kcnj11 Channel
D001786:Blood Glucose; D005905:Glyburide; D007004:Hypoglycemic Agents; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D000099161:Kcnj11 Channel